Have a question or topic idea for The Life Science Report? Submit it here.
The Current and Future Landscape of Healthcare IPO Markets
Airdate: November 7, 2023
Healthcare rallies as the second-largest industry behind technology in the stock market, and in the US markets there’s been roughly $2.5B raised from an IPO standpoint YTD. In Europe, the markets have been more challenging, with IPOs for five companies going public this year, including Schott Pharma, Germany’s largest IPO earlier this year.
In the first episode with the DNB//Back Bay Partnership for Healthcare, Jonathan Gertler, Back Bay CEO and Managing Partner, is joined by Jim Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director and Head of Equity Capital Markets at DNB, and Vasilios Kofitsas, Partner and Managing Director of Investment Banking at Back Bay Life Science Advisors to discuss the current landscape of IPO and capital markets, optimal preparation strategies for companies hoping to go public and why it matters who you spend your time with.
Listen to the full episode here.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher